tiprankstipranks
Trending News
More News >
Iridex Corp (IRIX)
NASDAQ:IRIX
US Market

Iridex (IRIX) Earnings Dates, Call Summary & Reports

Compare
129 Followers

Earnings Data

Report Date
Aug 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -9.09%
|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted several positive aspects, including revenue and EBITDA growth, successful cost reductions, and strategic investments, which were offset by some challenges in retina product revenue and regional sales declines. Despite the net loss, the company's trajectory towards profitability appears promising.
Company Guidance
During the First Quarter 2025 IRIDEX Earnings Conference Call, several key financial metrics and strategic goals were discussed. IRIDEX reported revenue of $11.9 million, a slight increase from $11.8 million in Q1 2024, with a notable 8% year-over-year growth in the Cyclo G6 product family revenue. The company achieved a positive adjusted EBITDA of $0.4 million, marking a $2.9 million improvement compared to the previous year. Gross profit for the quarter was $5.1 million, translating to a gross margin of 42.5%, up from 37.9% in Q1 2024, due to favorable product mix and reduced manufacturing expenses. Operating expenses were significantly reduced by $2.5 million year-over-year, leading to a net loss of $1.7 million, improving from a $3.5 million net loss in the prior year period. IRIDEX also strengthened its financial position with a $10 million strategic investment from Novel Inspiration in March 2025, which helped settle existing debt and enhance liquidity, with cash and cash equivalents totaling $7.2 million at the end of the quarter. The company remains focused on achieving cash flow breakeven and positive adjusted EBITDA for the year, driven by disciplined cost management and strategic initiatives to expand product adoption and market reach.
Revenue and EBITDA Growth
IRIDEX reported revenue of $11.9 million for Q1 2025, a slight increase from $11.8 million in Q1 2024. Achieved positive adjusted EBITDA of $0.4 million, an improvement of $2.9 million compared to the prior year quarter.
Cost Reduction and Profitability
Operating expenses decreased by $2.5 million to $5.3 million in Q1 2025 from $7.8 million in Q1 2024, driven by workforce reductions and lower discretionary spending, resulting in improved profitability.
Strategic Investment and Balance Sheet Strengthening
Received a $10 million strategic investment from Novel Inspiration, which strengthened the balance sheet and helped settle the Lind note payable.
Product Performance in Glaucoma Segment
Cyclo G6 product family revenue grew 8% year-over-year, primarily driven by higher probe sales, with MP3 probe unit sales exceeding expectations.
International Market Growth
Strong sales in EMEA and Asia, with regulatory approvals driving capital equipment sales. Medical retina sales in China showed a healthy recovery.
---

Iridex (IRIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IRIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 07, 2025
2025 (Q2)
- / -
May 13, 2025
2025 (Q1)
- / -0.10
-0.2152.38% (+0.11)
Mar 27, 2025
2024 (Q4)
- / -0.05
-0.1872.22% (+0.13)
Nov 12, 2024
2024 (Q3)
-0.09 / -0.12
-0.11-9.09% (>-0.01)
Aug 08, 2024
2024 (Q2)
-0.12 / -0.16
-0.175.88% (+0.01)
May 14, 2024
2024 (Q1)
-0.12 / -0.21
-0.13-61.54% (-0.08)
Mar 26, 2024
2023 (Q4)
-0.05 / -0.18
-0.07-157.14% (-0.11)
Nov 14, 2023
2023 (Q3)
-0.13 / -0.11
-0.110.00% (0.00)
Aug 10, 2023
2023 (Q2)
-0.11 / -0.17
-0.14-21.43% (-0.03)
May 11, 2023
2023 (Q1)
-0.12 / -0.13
-0.1513.33% (+0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

IRIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
$1.10$1.00-9.09%
Mar 27, 2025
$0.88$1.00+13.64%
Nov 12, 2024
$1.41$1.89+34.04%
Aug 08, 2024
$1.87$1.86-0.53%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Iridex Corp (IRIX) report earnings?
Iridex Corp (IRIX) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
    What is Iridex Corp (IRIX) earnings time?
    Iridex Corp (IRIX) earnings time is at Aug 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IRIX EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis